Showing 4571-4580 of 7540 results for "".
- Galderma and Chugai Announce Global License Agreement for Nemolizumab, Novel Biologic for Skin Diseaseshttps://practicaldermatology.com/news/galderma-and-chugai-announce-global-license-agreement-for-nemolizumab-novel-biologic-for-skin-diseases/2458496/Chugai Pharmaceutical Co., Ltd. and Galderma Pharma S.A. have entered into a global license agreement for nemolizumab (CIM331), the anti-IL-31 receptor A humanized monoclonal antibody created by Chugai, which is currently under development for atopic dermatitis and pruritus in hemodialysis patien
- ASDS: Interest in Cosmetic Surgery On the Risehttps://practicaldermatology.com/news/asds-interest-in-cosmetic-surgery-on-the-rise/2458498/Nearly six in 10 individuals are considering a cosmetic medical procedure today, up 50 percent since 2013, according to the annual American Society for Dermatologic Surgery (ASDS) Consumer Survey on Cosmetic Dermatologic Procedur
- FDA Clears Syneron Candela's UltraShape Power for Fat Destructionhttps://practicaldermatology.com/news/fda-clears-syneron-candelas-ultrashape-power-for-fat-destruction/2458499/The FDA cleared Syneron Medical Ltd.'s non-invasive fat destruction device, UltraShape Power. for non-invasive reduction of abdominal circumference via fat cell destruction. UltraShape Power uses focused, pulsed mechanical ultrasound energy to target and destroy fat, offering measurab
- FDA Advisory Committee Votes to Approve Biosimilar Etanercept from Sandozhttps://practicaldermatology.com/news/fda-advisory-committee-votes-to-approve-biosimilar-etanercept-from-sandoz/2458502/The US FDA Arthritis Advisory Committee recommended approval of Sandoz's proposed biosimilar etanercept. The committee voted unanimously (20-0), in support of biosimilar etanercept for all five indications of the reference product, including rheumatoid arthritis (RA), plaque psoriasis (PsO),
- New International Index Suggests Skin Cancer More Prevalent in Developed Countrieshttps://practicaldermatology.com/news/new-international-index-suggests-skin-cancer-more-prevalent-in-developed-countries/2458504/The USA has the 9th highest diagnoses of skin cancer per capita annually, according to a new report from Derma.plus. New Zealand had the most cases of skin cancer per capita followed by Australia, Switzerland, Sweden, and
- Cynosure Receives Health Canada Authorization to Market SculpSure®https://practicaldermatology.com/news/cynosure-receives-health-canada-authorization-to-market-sculpsure/2458503/Cynosure, Inc. received Health Canada Authorization to Market SculpSure® for non-invasive lipolysis of the abdomen and flanks. SculpSure is a fat-reduction laser intended for individuals with a body mass index (BMI) of 30 or less. The
- Topix Pharmaceuticals Partners with New Mountain Capitalhttps://practicaldermatology.com/news/new-mountain-capital-partners-with-topix-pharmaceuticals/2458505/Topix Pharmaceuticals, Inc. has partnered with New Mountain Capital, LLC, a growth-oriented investment firm that currently manages over $15 billion in assets. New Mountain, a New York-based private equity firm, identified Topix through a proactive focus in the life sciences and aestheti
- Study: Primary Care Melanoma Screening Does Not Lead to Overtreatmenthttps://practicaldermatology.com/news/study-primary-care-melanoma-screening-does-not-lead-to-overtreatment/2458506/Melanoma screening in primary care practice does not lead to overtreatment, new research suggests. In the new study, primary care providers at the University of Pittsburgh Medical Center system received online training in melanoma screening and began looking for the skin cancers in
- Allergan Research: Women Seek Confidence Over Youthhttps://practicaldermatology.com/news/allergan-research-women-seek-confidence-over-youth/2458517/The desire to boost self-confidence is as important as tightening sagging skin among women seeking aesthetic treatments, according to new research from Allergan. The Changing Face of Beauty: A Global Report' comprises opinions on beauty and
- Dr. Ann Marshak-Rothstein Takes Home 2016 Lupus Insight Prize for Cutaneous Lupus Researchhttps://practicaldermatology.com/news/dr-ann-marshak-rothstein-takes-home-2016-lupus-insight-prize-for-cutaneous-lupus-research/2458520/Ann Marshak-Rothstein, PhD, a professor of Medicine/Rheumatology at the University of Massachusetts Medical received the 2016 Lupus Insight Prize for her research on cutaneous lupus. The award was announced at FOCIS 2016, the 16th Annual M